Literature DB >> 19563381

Review article: Bone density in patients with chronic kidney disease stages 4-5.

Susan M Ott1.   

Abstract

Skeletal fractures are common in dialysis patients. Bone density measurements predict fractures in the general population, but in patients with chronic kidney disease (CKD) there is limited ability to predict fractures with these techniques. A review of the literature in patients with CKD stage 5 shows that bone density in the cortical bone of the radius or hip is generally lower compared with normal reference ranges by about one to two standard deviations, whereas in the spine bone density tends to be closer to the average expected values. The bone density is not able to predict the underlying histology in patients with renal osteodystrophy. The serum PTH levels are inversely related to bone density in some studies, and not related in other studies, but none found a positive association of serum parathyroid hormone (PTH) and bone density. There are very few data about longitudinal changes of bone density in these patients, and also inadequate studies of whether osteoporosis medications are effective in this population. Therefore, at this time the clinical utility of bone density measurements in patients with CKD-5 is uncertain.

Entities:  

Mesh:

Year:  2009        PMID: 19563381     DOI: 10.1111/j.1440-1797.2009.01159.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  18 in total

1.  CKD-mineral and bone disorder: core curriculum 2011.

Authors:  Ranjani N Moorthi; Sharon M Moe
Journal:  Am J Kidney Dis       Date:  2011-10-21       Impact factor: 8.860

2.  Efficacy and safety of eldecalcitol, a new active vitamin D3 analog, in the bone metabolism of postmenopausal women receiving maintenance hemodialysis.

Authors:  Naomi Sasaki; Masataka Tsunoda; Ryota Ikee; Nobuo Hashimoto
Journal:  J Bone Miner Metab       Date:  2014-04-25       Impact factor: 2.626

Review 3.  Treatment of osteoporosis in renal insufficiency.

Authors:  Lydia G Schipper; Hanneke W H A Fleuren; Joop P W van den Bergh; Johan R Meinardi; Bart A J Veldman; Cornelis Kramers
Journal:  Clin Rheumatol       Date:  2015-01-29       Impact factor: 2.980

4.  Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.

Authors:  M J Pérez-Sáez; S Herrera; D Prieto-Alhambra; L Vilaplana; X Nogués; M Vera; D Redondo-Pachón; M Mir; R Güerri; M Crespo; A Díez-Pérez; J Pascual
Journal:  Osteoporos Int       Date:  2017-05-11       Impact factor: 4.507

Review 5.  Low-trauma fractures without osteoporosis.

Authors:  E Lespessailles; B Cortet; E Legrand; P Guggenbuhl; C Roux
Journal:  Osteoporos Int       Date:  2017-02-04       Impact factor: 4.507

6.  Forearm bone mass predicts mortality in chronic hemodialysis patients.

Authors:  Lidija Orlic; Ivana Mikolasevic; Zeljka Crncevic-Orlic; Ivan Jakopcic; Josipa Josipovic; Drasko Pavlovic
Journal:  J Bone Miner Metab       Date:  2016-07-27       Impact factor: 2.626

Review 7.  Therapy for patients with CKD and low bone mineral density.

Authors:  Susan M Ott
Journal:  Nat Rev Nephrol       Date:  2013-10-08       Impact factor: 28.314

8.  Relationship between mild-to-moderate chronic kidney disease and decreased bone mineral density in Chinese adult population.

Authors:  Xianglei Kong; Lijun Tang; Xiaojing Ma; Weiwei Liu; Zunsong Wang; Meiyu Cui; Dongmei Xu
Journal:  Int Urol Nephrol       Date:  2015-08-12       Impact factor: 2.370

9.  [Value of serum alkaline phosphatase for predicting 2-year fracture in patients with chronic kidney disease on dialysis].

Authors:  Jianyi Pan; Haitang Hu; Wei Zhang; Jinzhong Chen; Xianrui Dou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-08-30

10.  Severe secondary hyperparathyroidism and panoramic radiography parameters.

Authors:  João César Guimarães Henriques; Julio Cezar de Melo Castilho; Reinhilde Jacobs; José Benedito Oliveira Amorim; Rafaela Rangel Rosa; Caio Vinícius Bardi Matai
Journal:  Clin Oral Investig       Date:  2013-07-12       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.